All is not lost: learning from 9p21 loss in cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Trends in immunology"
DOI: 10.1016/j.it.2022.03.003
Abstract: The cancer research community continues to search for additional biomarkers of response and resistance to immune checkpoint treatment (ICT). The ultimate goal is to direct the use of ICT in patients whose tumors are most… read more here.
Keywords: 9p21 loss; loss; cancer; loss cancer ... See more keywords